Exalenz Bioscience (Israel) Valuation Overview

EXEN -- Israel Stock  

ILS 1,014  1.00  0.1%

Exalenz Bioscience prevailing Real Value cannot be determined due to lack of data. The current price of Exalenz Bioscience is S1014.0. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Macroaxis computes value of Exalenz Bioscience from reviewing the firm fundamentals such as Current Valuation of 379.19M, Operating Margin of (39.94)% and Shares Outstanding of 25.56M as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since at some point assets prices and their ongoing real values will submerge.
Horizon     30 Days    Login   to change
Exalenz Bioscience Ltd is one of the top stocks in price to book category among related companies. It is rated # 3 in price to sales category among related companies fabricating about  0.01  of Price to Sales per Price to Book. The ratio of Price to Book to Price to Sales for Exalenz Bioscience Ltd is roughly  150.61 

Current Market Valuation

Exalenz Bioscience Valuation Boundaries

Not valued
October 21, 2018
1,014
Market Value
0.00
Real Value
Target Odds
  
0.00
Upside
Exalenz Bioscience is Unknown risk asset. Calculation of real value of Exalenz Bioscience is based on 1 month time horizon. Increasing Exalenz Bioscience time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Additionally see Investing Opportunities. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Search macroaxis.com